QQ
微信
| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| Ontuxizumab | Ontuxizumab | 946415-62-9 |
| Emactuzumab | Emactuzumab | 1448221-67-7 |
| Zenocutuzumab | Zenocutuzumab | 1969309-56-5 |
| Ifabotuzumab | IFABOTUZUMAB | 1234137-51-9 |
| Pateclizumab | 帕替组单抗 | 1202526-59-7 |
| Bezlotoxumab | Bezlotoxumab | 1246264-45-8 |
| Cosfroviximab | Cosfroviximab | 1792982-57-0 |
| Maftivimab | MAFTIVIMAB (玛替韦单抗 ) | 2135632-36-7 |
| Astegolimab | ASTEGOLIMAB (艾特利单抗 ) | 2173054-79-8 |
| Prolgolimab | 帕洛利单抗 | 2093956-19-3 |
| Crizanlizumab | Crizanlizumab | 1690318-25-2 |
| Sofituzumab Vedotin | Sofituzumab Vedotin | 1418200-58-4 |
| Futuximab | Futuximab | 1310460-85-5 |
| Remtolumab | 壬托鲁单抗 | 1791410-27-9 |
| Murlentamab | Murlentamab | 2058047-65-5 |
| Cusatuzumab | 古妥珠单抗 | 1399546-01-0 |
| Glembatumumab | GLEMBATUMUMAB ( 格巴妥木单抗 ) | 1020264-78-1 |
| Iscalimab | 伊卡利单抗 | 2031153-61-2 |
| Laprituximab | Laprituximab | 1622327-38-1 |
| Tabituximab | Tabituximab | 1644134-10-0 |
